Novartis will be looking at the data for 60 day end point for the 223 patients so that suggest Novartis are staying on board.
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-312
-
- There are more pages in this discussion • 764 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 534 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.5¢ | 7170 | 1 |
View Market Depth
| Last trade - 09.37am 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable